BWM
GILD icon

BAM Wealth Management’s Gilead Sciences GILD Stock Holding History

BAM Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,529
Closed -$213K – 178
2026
Q1 		$213K Buy
+1,529
New +$214K 0.16% 148

Other funds holding GILD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BAM Wealth Management's GILD Position: Q2 2026 in Review

BAM Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,529 shares — an estimated $213K sold.

BAM Wealth Management first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $213K in Q1 2026. 1,323 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BAM Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • BAM Wealth Management sold 1,529 Gilead Sciences shares in Q2 2026, an estimated $213K.
  • BAM Wealth Management first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • BAM Wealth Management's Gilead Sciences position peaked at $213K in Q1 2026.
  • 1,323 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BAM Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.